176 related articles for article (PubMed ID: 32175798)
1. The histone demethylase KDM2B activates FAK and PI3K that control tumor cell motility.
Zacharopoulou N; Kallergi G; Alkahtani S; Tsapara A; Alarifi S; Schmid E; Sukkar B; Kampranis S; Lang F; Stournaras C
Cancer Biol Ther; 2020 Jun; 21(6):533-540. PubMed ID: 32175798
[TBL] [Abstract][Full Text] [Related]
2. The epigenetic factor KDM2B regulates cell adhesion, small rho GTPases, actin cytoskeleton and migration in prostate cancer cells.
Zacharopoulou N; Tsapara A; Kallergi G; Schmid E; Tsichlis PN; Kampranis SC; Stournaras C
Biochim Biophys Acta Mol Cell Res; 2018 Apr; 1865(4):587-597. PubMed ID: 29408056
[TBL] [Abstract][Full Text] [Related]
3. The Epigenetic Factor KDM2B Regulates EMT and Small GTPases in Colon Tumor Cells.
Zacharopoulou N; Tsapara A; Kallergi G; Schmid E; Alkahtani S; Alarifi S; Tsichlis PN; Kampranis SC; Stournaras C
Cell Physiol Biochem; 2018; 47(1):368-377. PubMed ID: 29772566
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of lysine (K)-specific demethylase 2B KDM2B inhibits glycolysis and induces autophagy in lung squamous cell carcinoma cells by regulating the phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway.
Xie Z; Li H; Zang J
Bioengineered; 2021 Dec; 12(2):12227-12235. PubMed ID: 34783291
[TBL] [Abstract][Full Text] [Related]
5. Histone demethylase KDM2B promotes triple negative breast cancer proliferation by suppressing p15INK4B, p16INK4A, and p57KIP2 transcription.
Zheng Q; Fan H; Meng Z; Yuan L; Liu C; Peng Y; Zhao W; Wang L; Li J; Feng J
Acta Biochim Biophys Sin (Shanghai); 2018 Sep; 50(9):897-904. PubMed ID: 30060056
[TBL] [Abstract][Full Text] [Related]
6. KDM2B is involved in the epigenetic regulation of TGF-β-induced epithelial-mesenchymal transition in lung and pancreatic cancer cell lines.
Wanna-Udom S; Terashima M; Suphakhong K; Ishimura A; Takino T; Suzuki T
J Biol Chem; 2021; 296():100213. PubMed ID: 33779563
[TBL] [Abstract][Full Text] [Related]
7. KDM2B is a histone H3K79 demethylase and induces transcriptional repression via sirtuin-1-mediated chromatin silencing.
Kang JY; Kim JY; Kim KB; Park JW; Cho H; Hahm JY; Chae YC; Kim D; Kook H; Rhee S; Ha NC; Seo SB
FASEB J; 2018 Oct; 32(10):5737-5750. PubMed ID: 29763382
[TBL] [Abstract][Full Text] [Related]
8. Lysine demethylase 2B regulates angiogenesis via Jumonji C dependent suppression of angiogenic transcription factors.
Sasaki Y; Higashijima Y; Suehiro JI; Sugasawa T; Oguri-Nakamura E; Fukuhara S; Nagai N; Hirakawa Y; Wada Y; Nangaku M; Kanki Y
Biochem Biophys Res Commun; 2022 May; 605():16-23. PubMed ID: 35306360
[TBL] [Abstract][Full Text] [Related]
9. Combined expression levels of KDM2A and KDM2B correlate with nucleolar size and prognosis in primary breast carcinomas.
De Nicola I; Guerrieri AN; Penzo M; Ceccarelli C; De Leo A; Trerè D; Montanaro L
Histol Histopathol; 2020 Oct; 35(10):1181-1187. PubMed ID: 32901907
[TBL] [Abstract][Full Text] [Related]
10. CBP-triggered KDM2B acetylation accelerates the carcinogenesis of colon cancer.
Qi Y; Zhao Y
J Cell Physiol; 2020 Mar; 235(3):2901-2910. PubMed ID: 31531877
[TBL] [Abstract][Full Text] [Related]
11. KDM2B mediates the Wnt/β-catenin pathway through transcriptional activation of PKMYT1 via microRNA-let-7b-5p/EZH2 to affect the development of non-small cell lung cancer.
Zhang X; Yin Z; Li C; Nie L; Chen K
Exp Cell Res; 2022 Aug; 417(2):113208. PubMed ID: 35580699
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of microRNA let-7b expression by KDM2B promotes cancer progression by targeting EZH2 in ovarian cancer.
Kuang Y; Xu H; Lu F; Meng J; Yi Y; Yang H; Hou H; Wei H; Su S
Cancer Sci; 2021 Jan; 112(1):231-242. PubMed ID: 33091189
[TBL] [Abstract][Full Text] [Related]
13. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
[TBL] [Abstract][Full Text] [Related]
14. KDM2B, an H3K36-specific demethylase, regulates apoptotic response of GBM cells to TRAIL.
Kurt IC; Sur I; Kaya E; Cingoz A; Kazancioglu S; Kahya Z; Toparlak OD; Senbabaoglu F; Kaya Z; Ozyerli E; Karahüseyinoglu S; Lack NA; Gümüs ZH; Onder TT; Bagci-Onder T
Cell Death Dis; 2017 Jun; 8(6):e2897. PubMed ID: 28661478
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cell proliferation and induction of autophagy by KDM2B/FBXL10 knockdown in gastric cancer cells.
Zhao E; Tang C; Jiang X; Weng X; Zhong X; Zhang D; Hou J; Wang F; Huang M; Cui H
Cell Signal; 2017 Aug; 36():222-229. PubMed ID: 28506929
[TBL] [Abstract][Full Text] [Related]
16. Kdm2b maintains murine embryonic stem cell status by recruiting PRC1 complex to CpG islands of developmental genes.
He J; Shen L; Wan M; Taranova O; Wu H; Zhang Y
Nat Cell Biol; 2013 Apr; 15(4):373-84. PubMed ID: 23502314
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of amino acid metabolism by KDM2B, in the context of ncPRC1.1 and in concert with MYC and ATF4.
Chavdoula E; Anastas V; La Ferlita A; Aldana J; Carota G; Spampinato M; Soysal B; Cosentini I; Parashar S; Sircar A; Nigita G; Sehgal L; Freitas MA; Tsichlis PN
Metabolism; 2024 Jan; 150():155719. PubMed ID: 37935302
[TBL] [Abstract][Full Text] [Related]
18. KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs.
Tzatsos A; Paskaleva P; Ferrari F; Deshpande V; Stoykova S; Contino G; Wong KK; Lan F; Trojer P; Park PJ; Bardeesy N
J Clin Invest; 2013 Feb; 123(2):727-39. PubMed ID: 23321669
[TBL] [Abstract][Full Text] [Related]
19. HPV16 E6 and E7 upregulate the histone lysine demethylase KDM2B through the c-MYC/miR-146a-5p axys.
Peta E; Sinigaglia A; Masi G; Di Camillo B; Grassi A; Trevisan M; Messa L; Loregian A; Manfrin E; Brunelli M; Martignoni G; Palù G; Barzon L
Oncogene; 2018 Mar; 37(12):1654-1668. PubMed ID: 29335520
[TBL] [Abstract][Full Text] [Related]
20. Alternative isoforms of KDM2A and KDM2B lysine demethylases negatively regulate canonical Wnt signaling.
Lađinović D; Pinkas D; Šopin T; Raška O; Liška F; Raška I; Vacík T
PLoS One; 2020; 15(10):e0236612. PubMed ID: 33104714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
